2016_Head & Neck COURSE BOOK

First page Previous page 2076-2077 Next page Last page

Recurrent and/or metastatic non-curative disease

• Anti-EGFR first-line palliative treatment: mAbs

• Anti-EGFR second line: mAbs and TKIs

03/01/13

Made with